Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jitendra Ganju

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|April 28, 2006
Diagnostics for assumptions in moderate to large simple clinical trials: do they really help?Jitendra Ganju
Therapeutic Innovation & Regulatory Science|October 30, 2019
Improving the Standards of Reporting of Clinical Trial DataJitendra Ganju
Trials|July 22, 2016
Improving the operational efficiency of Phase 2 and 3 trialsJitendra Ganju
Statistics in Medicine|February 8, 2005
Analysis of clinical data with breached blindness: by Shein-Chung Chow and Jun Shao Statistics in Medicine 2004; 23:1185-1193Jitendra Ganju
Pharmaceutical Statistics|April 28, 2025
Why "Minimal Clinically Important Difference" for Interpreting the Magnitude of the Treatment Effect Is Not UsefulJitendra Ganju
Clinical Trials (London, England)|February 26, 2026
Commentary on "Shaping the future of clinical trials through strategic foresight"Jitendra Ganju
Therapeutic Innovation & Regulatory Science|December 10, 2020
Improving the Standards of Reporting of Clinical Trial DataJitendra Ganju
Biometrics|September 2, 2004
Some unexamined aspects of analysis of covariance in pretest-posttest studiesJitendra Ganju
Statistics in Medicine|September 10, 2011
The benefit of stratification in clinical trials revisitedJitendra Ganju, Kefei Zhou
Statistics in Medicine|April 2, 2005
A method to estimate the variance of an endpoint from an on-going blinded trialBiao Xing, Jitendra Ganju
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|April 28, 2006
Diagnostics for assumptions in moderate to large simple clinical trials: do they really help?Jitendra Ganju
Therapeutic Innovation & Regulatory Science|October 30, 2019
Improving the Standards of Reporting of Clinical Trial DataJitendra Ganju
Trials|July 22, 2016
Improving the operational efficiency of Phase 2 and 3 trialsJitendra Ganju
Statistics in Medicine|February 8, 2005
Analysis of clinical data with breached blindness: by Shein-Chung Chow and Jun Shao Statistics in Medicine 2004; 23:1185-1193Jitendra Ganju
Pharmaceutical Statistics|April 28, 2025
Why "Minimal Clinically Important Difference" for Interpreting the Magnitude of the Treatment Effect Is Not UsefulJitendra Ganju
Clinical Trials (London, England)|February 26, 2026
Commentary on "Shaping the future of clinical trials through strategic foresight"Jitendra Ganju
Therapeutic Innovation & Regulatory Science|December 10, 2020
Improving the Standards of Reporting of Clinical Trial DataJitendra Ganju
Biometrics|September 2, 2004
Some unexamined aspects of analysis of covariance in pretest-posttest studiesJitendra Ganju
Statistics in Medicine|September 10, 2011
The benefit of stratification in clinical trials revisitedJitendra Ganju, Kefei Zhou
Statistics in Medicine|April 2, 2005
A method to estimate the variance of an endpoint from an on-going blinded trialBiao Xing, Jitendra Ganju
Pageof 3